Pancreatic Cancer Research

ResearcherUniversità Campus Bio-MedicoActive in the last 2 years

Sara Ramella

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5782-7717; OpenAlex author ID A5039880019, A5073900558. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. Exploratory PET/CT Radiomics for Predicting Early Progression in Locally Advanced Pancreatic Cancer. Last author DOI 10.3390/diagnostics16101499↗
  2. In silico evaluation of the potential of very high energy electrons delivered in both conventional and FLASH regimes for the SBRT treatment of pancreatic cance… Co-author DOI 10.1016/j.ejmp.2025.105076↗
  3. Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging. Last author DOI 10.1016/j.ejso.2023.107257↗
  4. The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies. Co-author DOI 10.1097/js9.0000000000000755↗
  5. Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience. Last author DOI 10.3390/jcm13247739↗
  6. Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review. Last author DOI 10.21037/jgo-22-1034↗
  7. Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives. Co-author DOI 10.3390/biomedicines10092091↗
  8. CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis. Co-author DOI 10.3389/fonc.2021.690580↗
  9. A Bio-Imaging Signature as a Predictor of Clinical Outcomes in Locally Advanced Pancreatic Cancer. Last author DOI 10.3390/cancers12082016↗
  10. Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic canc… First author DOI 10.1038/srep45845↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michele Fiore · 10 shared papers, 2017–2026 · strength 1.78
  2. Damiano D. Caputo · 7 shared papers, 2017–2026 · strength 1.08
  3. Roberto Coppola · 6 shared papers, 2017–2024 · strength 0.81
  4. Vincenzo La Vaccara · 4 shared papers, 2021–2026 · strength 0.75
  5. Alessandro Coppola · 5 shared papers, 2020–2024 · strength 0.75
  6. Rolando Maria D’Angelillo · 3 shared papers, 2017–2024 · strength 0.45
  7. Angelica De Gregorio · 1 shared paper, 2025 · strength 0.20
  8. A. Sarti · 1 shared paper, 2025 · strength 0.20
  9. Roberto Cammarata · 1 shared paper, 2022 · strength 0.16
  10. Sergio Valeri · 1 shared paper, 2017 · strength 0.07
  11. Lucio Trodella · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.